You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Levodopa Induced Dyskinesia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Levodopa-Induced Dyskinesia, Parkinson's Disease Trial in Tucson (Intervention: Ketamine)

Active, not recruiting
  • Levodopa-Induced Dyskinesia
  • Parkinson's Disease
  • Intervention: Ketamine
  • Tucson, Arizona
    Scott J Sherman
Aug 27, 2023

Preventing Levodopa Induced Dyskinesia in Parkinson's Disease

Recruiting
  • Parkinson Disease
  • Dyskinesia, Drug-Induced
  • Intravenous Infusion
  • Portland, Oregon
  • +2 more
Dec 23, 2022

Levodopa-induced Dyskinesia, Parkinson's Disease Trial in Bunkyo (DSP-9632P 27.5 mg, DSP-9632P 82.5 mg, Placebo)

Recruiting
  • Levodopa-induced Dyskinesia
  • Parkinson's Disease
  • DSP-9632P 27.5 mg
  • +4 more
  • Bunkyo, Tokyo, Japan
    Nippon Medical School Hospital
Jun 23, 2022

Parkinson Disease, Dyskinesia, Medication-Induced Trial in Lublin, Warszawa, Oswiecim (CPL500036 - low dose, CPL500036 - high

Recruiting
  • Parkinson Disease
  • Dyskinesia, Medication-Induced
  • CPL500036 - low dose
  • +2 more
  • Lublin, Lubelskie, Poland
  • +3 more
May 9, 2022

Dyskinesias, Movement Disorders, CNS Diseases Trial in United States (Ketamine, Midazolam)

Active, not recruiting
  • Dyskinesias
  • +4 more
  • Tucson, Arizona
  • +6 more
Feb 16, 2022

Parkinson Disease, Dyskinesia, Medication-Induced, L-Dopa Causing Adverse Effects in Therapeutic Use Trial (AV-101, Placebo)

Not yet recruiting
  • Parkinson Disease
  • +2 more
  • (no location specified)
May 25, 2021

Medication-Induced Dyskinesia Trial in Sweden (NLX-112, Placebo)

Recruiting
  • Medication-Induced Dyskinesia
  • Gothenburg, Sweden
  • +4 more
Nov 24, 2021

Parkinson's Disease, Dyskinesias, Movement Disorders Trial in Portland (Buspirone, Placebo)

Terminated
  • Parkinson's Disease
  • +2 more
  • Portland, Oregon
    VA Portland Health Care System
Mar 3, 2021

Parkinson Disease, Dyskinesia, Drug-Induced, Dyskinesias Trial in United States (Dipraglurant)

Recruiting
  • Parkinson Disease
  • +2 more
  • Augusta, Georgia
  • +6 more
Apr 18, 2022

Parkinson's Disease, Levodopa Induced Dyskinesia (LID) Trial in Worldwide (amantadine HCl ER, Placebo)

Terminated
Has Results
  • Parkinson's Disease
  • Levodopa Induced Dyskinesia (LID)
  • amantadine HCl ER
  • Placebo
  • Tucson, Arizona
  • +55 more
Feb 14, 2022

Parkinson Disease Trial in Rome (Transcranial direct current stimulation)

Recruiting
  • Parkinson Disease
  • Transcranial direct current stimulation
  • Rome, Italy
    Flavia Torlizzi
Feb 21, 2023

Parkinson Disease, Dyskinesia, Drug-Induced, Dyskinesias Trial in United States (Dipraglurant, Placebo)

Recruiting
  • Parkinson Disease
  • +2 more
  • Phoenix, Arizona
  • +40 more
May 18, 2022

Parkinson Disease Trial in Rome (Continuous theta burst stimulation)

Recruiting
  • Parkinson Disease
  • Continuous theta burst stimulation
  • Rome, Italy
    Flavia Torlizzi
Mar 20, 2023

Dyskinesia, Drug-Induced, Parkinson Disease Trial (Safinamide Methanesulfonate 150mg, Safinamide Methanesulfonate 100mg,

Withdrawn
  • Dyskinesia, Drug-Induced
  • Parkinson Disease
  • Safinamide Methanesulfonate 150mg
  • +2 more
  • (no location specified)
Jun 15, 2020

Levodopa-Induced Dyskinesia Trial in Shanghai (Tianqi Pingchan Granule, Tianqi Pingchan Granule Placebo)

Unknown status
  • Levodopa-Induced Dyskinesia
  • Tianqi Pingchan Granule
  • Tianqi Pingchan Granule Placebo
  • Shanghai, Shanghai, China
    Xinhua Hospital Affiliated to Shanghai Jiao Tong University Scho
Nov 20, 2019

Parkinson Disease Trial in Port Orange, Decatur (Lenrispodun, Placebo)

Recruiting
  • Parkinson Disease
  • Port Orange, Florida
  • +1 more
Mar 10, 2023

Dyskinesia, Levodopa Induced Dyskinesia (LID), Parkinson's Disease (PD) Trial in Worldwide (ADS-5102)

Completed
Has Results
  • Dyskinesia
  • +2 more
  • Birmingham, Alabama
  • +86 more
Sep 15, 2020

Parkinson's Disease, Levodopa Induced Dyskinesias (LID) Trial in Worldwide (240mg Amantadine HCl ER tablets, Placebo tablets,

Terminated
Has Results
  • Parkinson's Disease
  • Levodopa Induced Dyskinesias (LID)
  • 240mg Amantadine HCl ER tablets
  • +2 more
  • Tucson, Arizona
  • +55 more
Feb 14, 2022

Parkinson Disease Trial in Sweden, United Kingdom (Mesdopetam (IRL790))

Completed
Has Results
  • Parkinson Disease
  • Mesdopetam (IRL790)
  • Göteborg, Sweden
  • +19 more
Mar 17, 2022

Dyskinesia, Drug-Induced, Parkinson Disease Trial in Hvidovre (Repetitive transcranial magnetic stimulation)

Completed
  • Dyskinesia, Drug-Induced
  • Parkinson Disease
  • Repetitive transcranial magnetic stimulation
  • Hvidovre, Capital Region, Denmark
    Danish Research Centre for Magnetic Resonance
Aug 3, 2019

Parkinson Disease, Dyskinesia, Drug-Induced, Levodopa Trial in Worldwide (AFQ056)

Completed
  • Parkinson Disease
  • +2 more
  • Sunnyvale, California
  • +21 more
Dec 15, 2020

Parkinson Disease Trial in Portland (GOCOVRI)

Recruiting
  • Parkinson Disease
  • Portland, Oregon
    Oregon Health & Science University
Dec 1, 2021

Parkinson Disease Trial in Dhaka (Doxycycline, Placebo)

Recruiting
  • Parkinson Disease
  • Dhaka, Bangladesh
    Bangabandhu Sheikh Mujib Medical University (BSMMU)
Aug 4, 2022

Fluctuating Parkinson's Disease With Sensor-based Home

Completed
  • Parkinson Disease
    • Ramat Gan, Israel
      Movement Disorders Institution, Sheba Medical Center
    Feb 15, 2022

    Parkinson Disease Trial in Pozzilli (targeted resequencing)

    Recruiting
    • Parkinson Disease
    • targeted resequencing
    • Pozzilli, Italy
      IRCCS Neuromed
    Sep 27, 2022